Divestiture • Medical Products

SipNose Acquires SipNose - Device Technology Assets

On October 9, 2024, SipNose acquired medical products company SipNose - Device Technology Assets from Aptar Pharma

Acquisition Context
  • This is SipNose’s 1st transaction in the Medical Products sector.
  • This is SipNose’s 1st transaction in Israel.

Explore All 633 Divestiture Medical Products Deals - Search the Database Free


M&A Deal Summary

Date October 9, 2024
Target SipNose - Device Technology Assets
Sector Medical Products
Buyer(s) SipNose
Sellers(s) Aptar Pharma
Deal Type Divestiture

Target Company

SipNose - Device Technology Assets

Yokneam, Israel
SipNose's Device Technology Assets includes a variety of devices technology assets that are designed and adapted to fit a wide range of therapies. SipNose's Device Technology Assets is based in Yokneam, Israel.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

SipNose


Category Company
DESCRIPTION


Deal Context for Buyer #
Overall 1 of 1
Sector: Medical Products 1 of 1
Type: Divestiture 1 of 1
Country: Israel 1 of 1
Year: 2024 1 of 1

Seller Profile 1

SELLER

Aptar Pharma

Crystal Lake, Illinois, United States

Category Company
Sector Medical Products
DESCRIPTION

Aptar Pharma offers drug delivery systems, services and active material science solutions. Aptar Pharma is based in Crystal Lake, Illinois.


Deal Context for Seller #
Overall 1 of 1
Sector: Medical Products 1 of 1
Type: Divestiture 1 of 1
Country: Israel 1 of 1
Year: 2024 1 of 1

Explore Related M&A Activity